Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome ; volume:11 ; number:1 ; day:6 ; month:1 ; year:2023 ; pages:1-4 ; date:12.2023
Acta Neuropathologica Communications ; 11, Heft 1 (6.1.2023), 1-4, 12.2023
- Creator
-
Guerrini-Rousseau, Léa
Tauziède-Espariat, Arnault
Castel, David
Rouleau, Etienne
Sievers, Philipp
Saffroy, Raphaël
Beccaria, Kévin
Blauwblomme, Thomas
Hasty, Lauren
Bourdeaut, Franck
Grill, Jacques
Varlet, Pascale
Debily, Marie-Anne
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-022-01490-w
- URN
-
urn:nbn:de:101:1-2023031522083741669549
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guerrini-Rousseau, Léa
- Tauziède-Espariat, Arnault
- Castel, David
- Rouleau, Etienne
- Sievers, Philipp
- Saffroy, Raphaël
- Beccaria, Kévin
- Blauwblomme, Thomas
- Hasty, Lauren
- Bourdeaut, Franck
- Grill, Jacques
- Varlet, Pascale
- Debily, Marie-Anne
- SpringerLink (Online service)
Other Objects (12)
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
A prognostic neural epigenetic signature in high-grade glioma
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
A prognostic neural epigenetic signature in high-grade glioma
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy